LP-196 Low-dose IL-2 therapy in SLE: efficacy on organ involvement, response predictors and synergistic effects with glucocorticoid treatment

Abstract

BackgroundLow-dose IL-2 supplementation is a promising treatment of SLE. However, in most of current studies, lack of appropriate control groups lead to uncertainty on its efficacy. We conducted a randomized...